高级检索
张希, 苏征, 徐慧芳, 余艳琴, 李扬, 乔友林. 2009 — 2016年中国大陆女性HPV疫苗认知及接种意愿汇总分析[J]. 中国公共卫生, 2021, 37(12): 1726-1730. DOI: 10.11847/zgggws1135890
引用本文: 张希, 苏征, 徐慧芳, 余艳琴, 李扬, 乔友林. 2009 — 2016年中国大陆女性HPV疫苗认知及接种意愿汇总分析[J]. 中国公共卫生, 2021, 37(12): 1726-1730. DOI: 10.11847/zgggws1135890
ZHANG Xi, SU Zheng, XU Hui-fang, . Knowledge on and willingness to receive human papillomavirus vaccination among child-bearing women in mainland China, 2009 – 2016: a pooled analysis[J]. Chinese Journal of Public Health, 2021, 37(12): 1726-1730. DOI: 10.11847/zgggws1135890
Citation: ZHANG Xi, SU Zheng, XU Hui-fang, . Knowledge on and willingness to receive human papillomavirus vaccination among child-bearing women in mainland China, 2009 – 2016: a pooled analysis[J]. Chinese Journal of Public Health, 2021, 37(12): 1726-1730. DOI: 10.11847/zgggws1135890

2009 — 2016年中国大陆女性HPV疫苗认知及接种意愿汇总分析

Knowledge on and willingness to receive human papillomavirus vaccination among child-bearing women in mainland China, 2009 – 2016: a pooled analysis

  • 摘要:
      目的  了解中国女性对预防性人乳头瘤病毒(HPV)疫苗的认知和接种意愿,并探讨可能的影响因素。
      方法  采用汇总分析方法对2009 — 2016年中国开展的以人群为基础的HPV疫苗接种意愿调查研究进行汇总,收集调查对象基本信息、对HPV疫苗的认知和接种意愿等信息进行整理和分析。
      结果  13 914名 ≤ 45岁女性纳入汇总分析, 3 353人(24.12 %)听说过HPV疫苗,10 592人(76.12 %)愿意接种HPV疫苗。不愿意接种疫苗的原因是:认为没有罹患HPV相关疾病的风险(52.73 %)、疫苗尚未大范围使用(34.98 %)及疫苗的有效性(31.72 %)和安全性(30.30 %)。仅3 094人(24.14 %)和1 628人(12.72 %)愿意支付 ≥ 1 000元/三剂购买进口和国产HPV疫苗,2 254人(17.59 %)和3 528人(27.56 %)仅愿意支付 < 100元/三剂购买进口和国产HPV疫苗。
      结论  2009 — 2016年期间,中国女性对HPV疫苗的认知水平较低,但接种意愿较高。增加HPV疫苗相关的公众教育、降低疫苗的价格对未来我国HPV疫苗的推广和普及十分必要。

     

    Abstract:
      Objective   To examine situations and influencing factors of the knowledge about and the intention to receive prophylactic human papillomavirus (HPV) vaccine among child-bearing women in mainland China.
      Methods  The information on 13 914 women aged ≤ 45 years were extracted from five population-based surveys in women on HPV vaccination intention conducted across mainland China between 2009 and 2016. Pooled analysis was performed on the data collected.
      Results   Of all the participants, only 3 353 (24.12%) had heard of HPV vaccine and 10 592 (76.12%) reported the willingness to receive HPV vaccine. Main reasons for the participants not having the vaccination intention included without perceived-risk of developing HPV-related diseases (reported by 52.73% of the participants), the vaccine being not yet widely vaccinated (34.98%), and wearing about the vaccine′s effectiveness (31.72%) and safety (30.30%). Among the participants with valid responses, only 3 094 (24.14%) and 1 628 (12.72%) were willing to pay ≥ 1 000 RMB yuan/three doses for imported and domestic HPV vaccines; but 2 254 (17.59%) and 3 528 (27.56%) were willing to pay < 100 RMB yuan/three doses for imported and domestic HPV vaccine, respectively.
      Conclusion  For the period of 2009 – 2016, the knowledge about HPV vaccine was at a low level but the willingness to receive the vaccine was high among child-bearing women in mainland China. The results suggest that increasing HPV vaccine related health education in the public and reducing the price of HPV vaccines are necessary for the promotion and popularization of HPV vaccination in China.

     

/

返回文章
返回